Gut Bacterial Dysbiosis in Children with Intractable Epilepsy
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
A few published clinical studies have evaluated the association between gut microbiota in intractable epilepsy, but with inconsistent results. We hypothesized that the factors associated with the gut bacterial composition, such as age and geography, contributed to the discrepancies. Therefore, we used a cohort that was designed to minimize the effects of possible confounding factors and compared the gut microbiota between children with intractable epilepsy and healthy controls. Eight children with intractable epilepsy aged 1 to 7 years and 32 age-matched healthy participants were included. We collected stool samples and questionnaires on their diet and bowel habits at two time points and analyzed the gut microbiota compositions. In the epilepsy group, the amount of Bacteroidetes was lower (Mann–Whitney test, false discovery rate (FDR) < 0.01) and the amount of Actinobacteria was higher (FDR < 0.01) than in the healthy group. The epilepsy subjects were 1.6- to 1.7-fold lower in microbiota richness indices (FDR < 0.01) and harbored a distinct species composition (p < 0.01) compared to the healthy controls. Species biomarkers for intractable epilepsy included the Enterococcus faecium group, Bifidobacterium longum group, and Eggerthella lenta, while the strongest functional biomarker was the ATP-binding cassette (ABC) transporter. Our study identified gut bacterial dysbiosis associated with intractable epilepsy within the cohort that was controlled for the factors that could affect the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In pediatric population, there were differences in diversity and composition of gut microbiota between children with drug-resistant resistant epilepsy and healthy children but both increased alpha-diversity [347] and decreased alpha-diversity [349,359] were reported.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [349]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · cited 1×
“, β-diversity metrics) and biomarker discovery analyses [21,22].”
BackgroundPredictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
Yoon, S.-H., Ha, S.-M., Kwon, S., Lim, J., Kim, Y., Seo, H., & Chun, J. (2017) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijsem.0.001755 · Cited by 7,702 · cited 1×
“The hyper-variable region (V3–V4) of the bacterial 16S rRNA was amplified using 341F and 805R primers [20].”
MethodEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002601107 · Cited by 4,774 · cited 1×
“We presumed that the lack of consensus could be the result of inconsistency in their control over the confounding factors, such as age [23,24], body mass index [25], type of diet [26–30], modes of delivery [31,32], or recent antibiotic exposure [33], which are known to have an influence over the gut microbiota.”
BackgroundDynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.004 · Cited by 3,315
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
Temporal development of the gut microbiome in early childhood from the TEDDY study
Stewart, C. J., Ajami, N. J., O’Brien, J. L., Hutchinson, D. S., Smith, D. P., Wong, M. C., Ross, M. C., Lloyd, R. E., Doddapaneni, H., Metcalf, G. A., et al. (2018) · Nature · doi:10.1038/s41586-018-0617-x · Cited by 2,014 · cited 1×
“The bacterial community properties that we found to be associated with epilepsy overlapped with the typical attributes in an immature gut microbiome: lower diversity and lower Bacteroidetes abundance have together been described as characteristics of a relatively immature gut microbiome within the context of age (asso…”
BackgroundExtensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905 · cited 1×
“However, none of the 16 drugs in the N03A (Anatomical Therapeutic Chemical classification) subgroup containing antiepileptic drugs have proven antibacterial effects in human studies [47].”
BackgroundThe Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., Corthier, G., & Furet, J.-P. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-123 · Cited by 1,755 · cited 1×
“We presumed that the lack of consensus could be the result of inconsistency in their control over the confounding factors, such as age [23,24], body mass index [25], type of diet [26–30], modes of delivery [31,32], or recent antibiotic exposure [33], which are known to have an influence over the gut microbiota.”
Background
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Microbiota–Gut–Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics
Ding, M., Lang, Y., Shu, H., Shao, J., & Cui, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742449 · Cited by 169
Roles of gut microbiome in epilepsy risk: A Mendelian randomization study
Zeng, Y., Cao, S., & Yang, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1115014 · Cited by 119
“identified Enterococcus faecium (species of class Bacilli), Bifidobacterium longum (species of genus Bifidobacterium), and Eggerthella lenta (species of phylum Actinobacteria) as biomarkers for drug-resistant epilepsy (Lee et al., 2021).”
BackgroundThe Microbiota–Gut–Brain Axis and Epilepsy
Yue, Q., Cai, M., Xiao, B., Zhan, Q., & Zeng, C. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01130-2 · Cited by 91
Dahlin, M. G., Singleton, S. S., David, J. A., Basuchoudhary, A., Wickström, R., Mazumder, R., & Prast‐Nielsen, S. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104061 · Cited by 74
The interplay between microbiota and brain-gut axis in epilepsy treatment
Zhu, H., Wang, W., & Li, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1276551 · Cited by 74
Lee, H., Lee, S., Lee, D.-H., & Kim, D. W. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106601 · Cited by 57
Evidences for a Role of Gut Microbiota in Pathogenesis and Management of Epilepsy
Amlerová, J., Šroubek, J., Angelucci, F., & Hort, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115576 · Cited by 61
Updates on the ketogenic diet therapy for pediatric epilepsy
Ko, A., Kwon, H. E., & Kim, H. D. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.11.003 · Cited by 61
“lead to reduced production of short-chain fatty acids and neurotransmitters such as GABA and serotonin [31,32].”
BackgroundIlhan, Z. E., Brochard, V., Lapaque, N., Auvin, S., & Lepage, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105664 · Cited by 52
Gut microbiota affects brain development and behavior
Kim, G.-H., & Shim, J. O. (2022) · Korean Journal of Pediatrics · doi:10.3345/cep.2021.01550 · Cited by 54
Self-citationZubareva, O. E., Dyomina, A. V., Kovalenko, A. A., Roginskaya, A. I., Melik-Kasumov, T. B., Korneeva, M. A., Chuprina, A. V., Zhabinskaya, A. A., Kolyhan, S. A., Zakharova, M. V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098451 · Cited by 44
The gut microbiota as a biomarker in epilepsy
Russo, E. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105598 · Cited by 46
Therapeutic potential of gut microbiota modulation in epilepsy: A focus on short-chain fatty acids
Yan, R., Zhang, L., Chen, Y., Zheng, Y., Ping, X., & Xu, Z. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106880 · Cited by 36
Gut-microbiota-directed strategies to treat epilepsy: clinical and experimental evidence
Granados, D. M. M., Villasana‐Salazar, B., Lozano‐García, L., Cavalheiro, É. A., & Striano, P. (2021) · Seizure · doi:10.1016/j.seizure.2021.03.009 · Cited by 35
Mazandarani, M., Lashkarbolouk, N., Ejtahed, H., & Qorbani, M. (2023) · Nutrition Journal · doi:10.1186/s12937-023-00893-2 · Cited by 33
“They found a reduction in seizure frequency after KD implementation in these patients [5, 7, 8, 10, 11, 16].”
BackgroundInfluentialOuyang, Y., Chen, Y., Wang, G., Song, Y., Zhao, H., Xiao, B., Yang, Z., & Long, L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.994270 · Cited by 27
Wang, J., Huang, L., Li, H., Chen, G., Yang, L. M., Wang, D., Han, H. J., Zheng, G., Wang, X., Liang, J., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1237255 · Cited by 25
“In addition, Actinobacteriota was significantly enriched in the control group, and Kihyun Lee identified it as a biomarker for epilepsy patients at the phylum level (37).”
BackgroundEpilepsy, gut microbiota, and circadian rhythm
Wang, Y., Zhuo, Z., & Wang, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1157358 · Cited by 23
“(34) Korea Intractable epilepsy (n = 8)”
ResultMousavi, S. M., Younesian, S., & Ejtahed, H. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107266 · Cited by 21
Liu, T., Jia, F., Guo, Y., Wang, Q., Zhang, X., Chang, F., & Xie, Y. X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1081591 · Cited by 19
“At the same time, gut-microbiota-based biomarkers are important for the differential diagnosis, prognosis and treatment monitoring of epilepsy (Gong et al., 2020; Lee et al., 2020a).”
BackgroundChojnowski, K., Opiełka, M., Urbanowicz, K., Zawadzka, M., Wangin, K., Smolenski, R. T., & Mazurkiewicz‐Bełdzińska, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-99805-z · Cited by 19
Changes in gut flora in patients with epilepsy: a systematic review and meta-analysis
He, X., & Zhang, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1480022 · Cited by 19
Díaz-Marugán, L., Rutsch, A., Kaindl, A. M., & Ronchi, F. (2024) · Acta Physiologica · doi:10.1111/apha.14104 · Cited by 18
Gut microbiome in neuropsychiatric disorders
Granados, D. M. M., Villasana‐Salazar, B., Coan, A. C., Rizzi, L., Balthazar, M. L. F., Godoi, A. B., do Canto, A. M., da Rosa, D. C., Silva, L. S., Tacla, R., et al. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2021-0052 · Cited by 22
Yang, R., Liu, J., Diao, L., Wei, L., Luo, H., & Cai, L. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.01.023 · Cited by 14
Drug-Resistant Epilepsy and Gut-Brain Axis: an Overview of a New Strategy for Treatment
Chen, S., Jiao, Y., Han, C. Q., Li, Y., Zou, W., & Liu, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03757-2 · Cited by 17
A long journey to treat epilepsy with the gut microbiota
Li, Q., Gu, Y., Liang, J., Yang, Z., & Qin, J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1386205 · Cited by 15
“The ATP-binding cassette (ABC) transporter-associated microbiota included the Enterococcus faecium group, the Bifidobacterium longum group, and the Eggerthella lenta , which are likely biomarkers of intractable epilepsy (Lee et al., 2020).”
BackgroundClocking Epilepsies: A Chronomodulated Strategy-Based Therapy for Rhythmic Seizures
Sun, S., & Wang, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044223 · Cited by 13
“Further, intractable epilepsy in children is comorbid with intestinal bacterial dysbiosis [288].”
BackgroundDai, W., Zhu, Y., Jiang, Z., Xiang, Y., Mao, X., & Liu, Z. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70253 · Cited by 12
Using integrated meta-omics to appreciate the role of the gut microbiota in epilepsy
Boeri, L., Donnaloja, F., Campanile, M., Sardelli, L., Tunesi, M., Fusco, F., Giordano, C., & Albani, D. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105614 · Cited by 11
“Feces kept at 4 °C until the freezing at -80 °C in the lab Homogenization, beadbeating, centrifugation at 14,000 g for 10 minutes (Lee et al., 2020)”
Changes in gut microbiome can be associated with abrupt seizure exacerbation in epilepsy patients
Kwack, D. W., Lee, S., Lee, D., & Kim, D. W. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108556 · Cited by 12
Dysbiosis in Children With Neurological Impairment and Long-Term Enteral Nutrition
Panelli, S., Calcaterra, V., Verduci, E., Comandatore, F., Pelizzo, G., Borghi, E., Bandi, C., & Zuccotti, G. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.895046 · Cited by 12
“(10) reported that children with intractable epilepsy (IE) had a significantly less variegate GM than healthy controls; Huang C et al.”
BackgroundTang, M., Wang, W., Wang, J., & Wang, Y. (2025) · Microorganisms · doi:10.3390/microorganisms13112539 · Cited by 11
“Notably, most studies showed that α -diversity in the HC group was higher than that in the DRE group [32,33,35,37,38].”
The role of the microbiota-gut-brain axis in schizophrenia: an immunological perspective
Su, B.-W., Li, Y., Yang, L.-Y., Yang, H., Wang, W., Ren, H., Bao, Y.-N., Lao, J.-Y., & Luan, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1711756 · Cited by 12
From clinical practice to mechanistic insights in ketogenic diets for epilepsy
Figueroa, A. G., Joshi, C., & Patel, M. (2026) · The Lancet Neurology · doi:10.1016/s1474-4422(26)00008-6 · Cited by 9
Li, F., You, D., Li, Y., Wang, X., Lin, Z., Shi, X., Li, Z., Wu, J., & Liu, Z. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1630062 · Cited by 10
The gut microbiome associated with LGI1 ‐antibody encephalitis
Gilbert, E. H., Binks, S. N. M., Damato, V., Uy, C. E., Colmenero, P., Kelly, M., Khalil, M. I., O’Brien, M., Claesson, M. J., Cryan, J. F., et al. (2025) · Epilepsia · doi:10.1111/epi.18556 · Cited by 6
“In addition, our cases were enriched for the Enterococcus and Haemophilus D genera, with depletion of the Dorea and Coprococcus genera, and the Firmicutes phylum (recently renamed Bacillota 27,28 ).”
Ketogenic diets therapy in the management of epileptic spasms syndrome
Wang, M., Zhao, F., Sun, L., Yu, Y., & Zhang, H. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1472982 · Cited by 7
“Currently, there is a degree of debate surrounding the hypothesis that KDT exerts an in fl uence on epilepsy by modulating the number of bi fi dobacteria (59 – 61).”
Kowalcze, K., Dyńka, D., Klus, W., Dudzińska, M., & Paziewska, A. (2025) · Nutrients · doi:10.3390/nu18010031 · Cited by 7
“Analysis of these data confirmed that patients with intractable epilepsy had gut bacterial dysbiosis [143].”
InfluentialZouganeli, S., Mitsou, E. K., Yannakoulia, M., Intze, E., Mountzouris, K. C., Fessatou, S., Attilakos, A., Kyriacou, A., & Dinopoulos, A. (2026) · Epileptic Disorders · doi:10.1002/epd2.70269 · Cited by 4
“34 45 These differences may reflect epilepsy-related dysbiosis as well as normal age-related variation between pediatric patients and adults.”
Guarnieri, L., Bosco, F., Ruga, S., Tallarico, M., Leo, A., Sarro, G. D., & Citraro, R. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04593-8 · Cited by 4
“These alterations of gut microbiota together with the underlying inflammation seem to contribute to the epileptic phenotype of WAG/Rij rats [28] as reported in epileptic patients [35].”
Yu, F., Ji, J., Wang, Y., Liu, Y., Lian, Y.-M., Wang, M., & Cai, Z.-X. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111401 · Cited by 4
Shrestha, A., Silveira, L. J., Thomas, D., Leech, J. D., Lai, Y., Riviello, J. J., Muscal, E., Soden, J. S., & Eschbach, K. L. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08345-x · Cited by 3
Barros, T. G. R., Modesto, J. V. C., de Paula, M. C. A., Rodrigues, R. R., Menegusse, R. B., Miranda, V. P. N., Toscano, E. C. D. B., & Martins, M. V. (2026) · Nutrition Reviews · doi:10.1093/nutrit/nuaf311 · Cited by 3
Luo, J., Luo, J., Zeng, L.-Y., & Chi, C.-L. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111609 · Cited by 2
Role of polyphenols in epilepsy: from the perspective of gut microbiota
Xu, X., Shi, J., Cai, G., Ma, C., Wang, W., Feng, R., Boczek, T., Tang, Y., He, Z., & Guo, F. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250303 · Cited by 1
“As shown in Figure.2, studies have shown that the distribution of fecal microbiota is different between patients with epilepsy and HC [88-92] .”
Antmen, F. M., Matpan, E., Dayanc, E. D., Savas, E. O., Eken, Y., Acar, D., Ak, A., Ozefe, B., Şakar, D., Canözer, U., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13030588 · Cited by 1
“Moreover, investigating these metabolites and pathways in clinical settings and diverse epilepsy models may facilitate the development of targeted therapeutic strategies and novel interventions.”
Analysis of treatment-naïve gut microbiota in children with new-onset epilepsy
Fujishiro, A., Tsuji, S., Akagawa, S., Fujishiro, S., Murakami, K., Araki, A., & Kaneko, K. (2026) · Pediatric Research · doi:10.1038/s41390-026-04996-4 · Cited by 1
Fu, X., Xie, Y., Xie, Y., Han, A., Zhou, X., Zhang, S., Shen, C., Zhang, Y., Wang, L., & Xie, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1860661 · Cited by 1
Zammar, K., AbuAlrob, M. A., Ali, M. A., Lattanzi, S., & Mesraoua, B. (2026) · Epilepsia Open · doi:10.1002/epi4.70325 · Cited by 1
“25 More recently, Riva et al. 23 identified a distinct gut microbial signature associated with medication-resistant epilepsy in a pediatric cohort, with Eubacterium deple-tion—a butyrate-and GABA-producing genus—correlat-ing with treatment resistance, further linking functional microbial output to…”
INTESTINAL MICROBIOME. EPILEPSY AND THE POSSIBILITY OF EXPANDING ALTERNATIVE THERAPIES
Богданова, Н. М., & Кравцова, К. А. (2023) · Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ) · doi:10.18499/1990-472x-2023-24-3-107-121 · Cited by 1
How to navigate the many direct-to-consumer microbiota analyses and why to use them
Pierro, F. D., Bertuccioli, A., Cazzaniga, M., Matera, M., Cavecchia, I., Gerardi, V., Piccirelli, S., Salvi, D., Pugliano, C. L., Cesaro, P., et al. (2024) · Minerva Gastroenterology · doi:10.23736/s2724-5985.24.03799-9 · Cited by 1
The microbiome: what a neurologist needs to know
Dehghanizai, A. B., Stewart, C. J., & Thomas, R. H. (2025) · Practical Neurology · doi:10.1136/pn-2024-004400 · Cited by 1
“22 Other carbohydrate-limited diets, such as the modified Atkins diet, are promising, as they are less strict—which is a boon for long-term adherence.”
InfluentialNew Horizon on Gut Microbiome and Cancers: Recent Information on Pathogenesis and Treatment
Fukui, H. (2022) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20221003.15
Arulsamy, A., & Shaikh, M. F. (2022) · Springer eBooks · doi:10.1007/978-981-19-3949-5_19-1
Arulsamy, A., & Shaikh, M. F. (2023) · Springer eBooks · doi:10.1007/978-981-19-3949-5_19-2 · Cited by 1
Correlação entre microbiota intestinal e distúrbios neurológicos
Leite, C. D. A. E. A., dos Santos, J. P. L., Armada, L., Leite, M. A. A., Barcellos, C. T., Tavares, T. D. M., & Orsini, M. A. (2024) · Enfermagem Brasil · doi:10.33233/eb.v22i6.5570
Advances in Ketogenic Diet-Mediated Gut Flora in Epilepsy
卢, 豫. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.143815
The gut microbiome associated with LGI1- and CASPR2-antibody encephalitisPreprint
Gilbert, E. H., Binks, S. N. M., Damato, V., Uy, C. E., Colmenero, P., Khalil, M. I., O’Brien, M., Claesson, M. J., Cryan, J. F., Delanty, N., et al. (2024) · medRxiv · doi:10.1101/2024.04.25.24305899
Arulsamy, A., & Shaikh, M. F. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_19
Zhabinskaya, A. A., Melik-Kasumov, T. B., & Pyzh, H. E. (2024) · Proceedings of the National Academy of Sciences of Belarus Medical series · doi:10.29235/1814-6023-2024-21-4-334-344
A personalized approach to the diagnosis of epilepsy in obese children
Mamedov, I. S., Perevesentsev, O. A., Кулакова, Е. Г., Владимировна, З. И., Tkacheva, M. I., Paramonov, S. A., Simenel, E. S., Tatarinov, P. A., & Krapivkin, A. I. (2025) · Laboratory Service · doi:10.17116/labs2025140115
Mazandarani, M., Lashkarbolouk, N., Ejtahed, H.-S., & Qorbani, M. (2024) · Figshare · doi:10.6084/m9.figshare.26642524
Mazandarani, M., Lashkarbolouk, N., Ejtahed, H.-S., & Qorbani, M. (2024) · Figshare · doi:10.6084/m9.figshare.26642521
Gut Microbiota: A Novel Perspective Linking Lithium Exposure to Epilepsy Risk
吴, 祺. (2025) · Bioprocess · doi:10.12677/bp.2025.154034
Kadandelu, M., Periya, S., Rekha, P. D., & Raghu, S. V. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0144
“Bi fi dum longum was found to be enriched in patients with intractable epilepsy when compared to the healthy controls and considered as a potential species-level biomarker for epilepsy (Lee et al. 2020) (Table 1).”
Zhang, X., Hu, X. M., Hao, X., Zhang, H., Tao, Z., & Liang, J. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1804171
Harnessing the gut microbiota: new frontiers in treating childhood epilepsy
Bejaoui, S., D’Amico, F., Messana, T., Candela, M., & Turroni, S. (2026) · Global Pediatrics · doi:10.1016/j.gpeds.2026.100354
Metabolic Outputs of the Gut Microbiome: Implications for Epilepsy
Gallucci, A., Guo, X., Shukla, D., & Campbell, S. L. (2026) · Cells · doi:10.3390/cells15161492
Metadata
- Authors
- Lee, K., Kim, N., Shim, J. O., & Kim, G.-H.
- Affiliations
- Chunlab, Inc., ChunLab Tower, 34 Samseong-ro 85-gil, Seoul 06194, Korea
- Korea University (KR)
- Korea Institute of Radiological and Medical Sciences (KR)
- Corresponding author
- Kim, Gun-Ha
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2020-12-22
- Volume
- 10
- Issue
- 1
- Pages
- 5
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7792797
- OpenAlex
- W3117869844
- Cited by
- 70
- References
- 47
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 18 · 2023: 10 · 2022: 9 · 2021: 8
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Science and ICT, South Korea (50543-2020)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- gut microbiota, bacterial dysbiosis, drug-resistant epilepsy, pediatric epilepsy, Bacteroidetes, actinobacteria, Enterococcus faecium, Bifidobacterium longum, Eggerthella lenta, ABC transporters
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.